Federico Triolo

Federico Triolo

Auto-generated profile, based on publicly available information

Federico Triolo

Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Mechanisms of Ageing and Development
Verified
Journal Article
Open access
FTFederico Triolo
Federico Triolo
LHLisa Harber-Aschan
Lisa Harber-Aschan
MMMartino Belvedeti Murri
Martino Belvedeti Murri
ACAmaia Calderón-Larrañaga
Amaia Calderón-Larrañaga
DVDavide L. Vetrano
Davide L. Vetrano
SDSerhiy Dekhtyar
Serhiy Dekhtyar
Multimorbidity and depression are complex multifactorial conditions with major implications for older individuals, their families, and healthcare providers. In this scoping review, we aimed to 1) review findings from longitudinal epidemiological studies investigating the association between multimorbidity and depression; 2) identify potential mechanisms linking multimorbidity and depression; 3) discuss challenges to advance the research field. Overall, evidence emerging from longitudinal studies supports a bidirectional association between the two conditions, although studies are methodologically heterogeneous in terms of design, inclusion criteria, measurement of multimorbidity and depression, and length of follow-up. A variety of biological, psychosocial, and care-related drivers may regulate the transition from multimorbidity to depression, and the other way around, although these mechanisms are yet to be explicitly verified. Further research is required to unravel the intricate interplay between multimorbidity, depression, their common drivers, and precipitating factors underlying the relationship between the two conditions. Understanding these processes will inform strategies aimed at promoting mental and physical health during aging.

1 February 2020 in Psychiatry Research
Verified
Journal Article
Closed access
MMMartino Belvedeti Murri
Martino Belvedeti Murri
FTFederico Triolo
Federico Triolo
ACAlice Coni
Alice Coni
CTCarlo Tacconi
Carlo Tacconi
ENErika Nerozzi
Erika Nerozzi
MAMario Amore
Mario Amore

1 October 2024 in Journal of Internal Medicine
Verified
Journal Article
Open access
GBGiuseppe Bellelli
Giuseppe Bellelli
FTFederico Triolo
Federico Triolo
Maria Cristina FerraraMaria Cristina Ferrara
Maria Cristina Ferrara
SDStacie G. Deiner
Stacie G. Deiner
AMAlessandro Morandi
Alessandro Morandi
DVDavide Liborio Vetrano
Davide Liborio Vetrano
Frailty and delirium are two common geriatric syndromes sharing several clinical characteristics, risk factors, and negative outcomes. Understanding their interdependency is crucial to identify shared mechanisms and implement initiatives to reduce the associated burden. This literature review summarizes scientific evidence on the complex interplay between frailty and delirium; clinical, epidemiological, and pathophysiological commonalities; and current knowledge gaps. We conducted a PubMed systematic search in June 2023, which yielded 118 eligible articles out of 991. The synthesis of the results—carried out by content experts—highlights overlapping risk factors, clinical phenotypes, and outcomes and explores the influence of one syndrome on the onset of the other. Common pathophysiological mechanisms identified include inflammation, neurodegeneration, metabolic insufficiency, and vascular burden. The review suggests that frailty is a risk factor for delirium, with some support for delirium associated with accelerated frailty. The proposed unifying framework supports the integration and measurement of both constructs in research and clinical practice, identifying the geroscience approach as a potential avenue to develop strategies for both conditions. In conclusion, we suggest that frailty and delirium might be alternative—sometimes coexisting—manifestations of accelerated biological aging. Clinically, the concepts addressed in this review can help approach older adults with either frailty or delirium from a different perspective. From a research standpoint, longitudinal studies are needed to explore the hypothesis that specific pathways within the biology of aging may underlie the clinical manifestations of frailty and delirium. Such research will pave the way for future understanding of other geriatric syndromes as well.

1 February 2023 in Age and Ageing
Verified
Journal Article
Open access
PDF file
FTFederico Triolo
Federico Triolo
LSLinnea Sjöberg
Linnea Sjöberg
ACAmaia Calderón-Larrañaga
Amaia Calderón-Larrañaga
MMMartino Belvederi Murri
Martino Belvederi Murri
DVDavide Liborio Vetrano
Davide Liborio Vetrano
SDSerhiy Dekhtyar
Serhiy Dekhtyar
Introduction: as late-life depression is associated with poor somatic health, we aimed to investigate the role of depression severity and symptom phenotypes in the progression of somatic multimorbidity.Methods: we analysed data from 3,042 dementia-free individuals (60+) participating in the population-based Swedish National Study on Aging and Care in Kungsholmen. Using the baseline clinical assessment of 21 depressive symptoms from the Comprehensive Psychopathological Rating Scale, we: (i) diagnosed major, minor (in accordance with DSM-IV-TR) and subsyndromal depression; (ii) extracted symptom phenotypes by applying exploratory network graph analysis. Somatic multimorbidity was measured as the number of co-occurring chronic diseases over a 15-year follow-up. Linear mixed models were used to explore somatic multimorbidity trajectories in relation to baseline depression diagnoses and symptom phenotypes, while accounting for sociodemographic and behavioural factors.Results: in multi-adjusted models, relative to individuals without depression, those with major (β per year: 0.33, 95% confidence interval [CI]: 0.06–0.61) and subsyndromal depression (β per year: 0.21, 95%CI: 0.12–0.30) experienced an accelerated rate of somatic multimorbidity accumulation, whereas those with minor depression did not. We identified affective, anxiety, cognitive, and psychomotor symptom phenotypes from the network analysis. When modelled separately, an increase in symptom score for each phenotype was associated with faster multimorbidity accumulation, although only the cognitive phenotype retained its association in a mutually adjusted model (β per year: 0.07, 95%CI: 0.03–0.10).Conclusions: late-life major and subsyndromal depression are associated with accelerated somatic multimorbidity. Depressive symptoms characterised by a cognitive phenotype are linked to somatic health change in old age.

30 October 2021 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
FTFederico Triolo
Federico Triolo
MMMartino Belvederi Murri
Martino Belvederi Murri
ACAmaia Calderón-Larrañaga
Amaia Calderón-Larrañaga
DVDavide Liborio Vetrano
Davide Liborio Vetrano
LSLinnea Sjöberg
Linnea Sjöberg
SDSerhiy Dekhtyar
Serhiy Dekhtyar
The clinical presentation of late-life depression is highly heterogeneous and likely influenced by the co-presence of somatic diseases. Using a network approach, this study aims to explore how depressive symptoms are interconnected with each other, as well as with different measures of somatic disease burden in older adults. We examined cross-sectional data on 2860 individuals aged 60+ from the Swedish National Study on Aging and Care in Kungsholmen, Stockholm. The severity of sixteen depressive symptoms was clinically assessed with the Comprehensive Psychopathological Rating Scale. We combined data from individual clinical assessment and health-registers to construct eight system-specific disease clusters (cardiovascular, neurological, gastrointestinal, metabolic, musculoskeletal, respiratory, sensory, and unclassified), along with a measure of overall somatic burden. The interconnection among depressive symptoms, and with disease clusters was explored through networks based on Spearman partial correlations. Bridge centrality index and network loadings were employed to identify depressive symptoms directly connecting disease clusters and depression.Sadness,pessimism,anxiety, andsuicidal thoughtswere the most interconnected symptoms of the depression network, while somatic symptoms of depression were less interconnected. In the network integrating depressive symptoms with disease clusters,suicidal thoughts,reduced appetite, andcognitive difficultiesconstituted the most consistent bridge connections. The same bridge symptoms emerged when considering an overall measure of somatic disease burden.Suicidal thoughts,reduced appetite,andcognitive difficultiesmay play a key role in the interconnection between late-life depression and somatic diseases. If confirmed in longitudinal studies, these bridging symptoms could constitute potential targets in the prevention of late-life depression.

8 February 2024 in Epidemiology and Psychiatric Sciences
Verified
Journal Article
Open access
PDF file
FTFederico Triolo
Federico Triolo
DVDavide Liborio Vetrano
Davide Liborio Vetrano
LSLinnea Sjöberg
Linnea Sjöberg
ACAmaia Calderón-Larrañaga
Amaia Calderón-Larrañaga
MMMartino Belvederi Murri
Martino Belvederi Murri
SDSerhiy Dekhtyar
Serhiy Dekhtyar
Aims: Co-occurring somatic diseases exhibit complex clinical profiles, which can differentially impact the development of late-life depression. Within a community-based cohort, we aimed to explore the association between somatic disease burden, both in terms of the number of diseases and their patterns, and the incidence of depression in older people. Methods: We analysed longitudinal data of depression- and dementia-free individuals aged 60+ years from the population-based Swedish National Study on Aging and Care in Kungsholmen. Depression diagnoses were clinically ascertained following the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Text Revision over a 15-year follow-up. Somatic disease burden was assessed at baseline through a comprehensive list of chronic diseases obtained by combining information from clinical examinations, medication reviews and national registers and operationalized as (i) disease count and (ii) patterns of co-occurring diseases from latent class analysis. The association of somatic disease burden with depression incidence was investigated using Cox models, accounting for sociodemographic, lifestyle and clinical factors. Results: The analytical sample comprised 2904 people (mean age, 73.2 [standard deviation (SD), 10.5]; female, 63.1%). Over the follow-up (mean length, 9.6 years [SD, 4 years]), 225 depression cases were detected. Each additional disease was associated with the occurrence of any depression in a dose–response manner (hazard ratio [HR], 1.16; 95% confidence interval [CI]: 1.08, 1.24). As for disease patterns, individuals presenting with sensory/anaemia (HR, 1.91; 95% CI: 1.03, 3.53), thyroid/musculoskeletal (HR, 1.90; 95% CI: 1.06, 3.39) and cardiometabolic (HR, 2.77; 95% CI: 1.40, 5.46) patterns exhibited with higher depression hazards, compared to those without 2+ diseases (multimorbidity). In the subsample of multimorbid individuals (85%), only the cardiometabolic pattern remained associated with a higher depression hazard compared to the unspecific pattern (HR, 1.71; 95% CI: 1.02, 2.84). Conclusions: Both number and patterns of co-occurring somatic diseases are associated with an increased risk of late-life depression. Mental health should be closely monitored among older adults with high somatic burden, especially if affected by cardiometabolic multimorbidity.